90 related articles for article (PubMed ID: 2825982)
1. Reduction of doxorubicin cytotoxicity by ouabain: correlation with topoisomerase-induced DNA strand breakage in human and hamster cells.
Lawrence TS
Cancer Res; 1988 Feb; 48(3):725-30. PubMed ID: 2825982
[TBL] [Abstract][Full Text] [Related]
2. Dependence of etoposide-induced cytotoxicity and topoisomerase II-mediated DNA strand breakage on the intracellular ionic environment.
Lawrence TS; Canman CE; Maybaum J; Davis MA
Cancer Res; 1989 Sep; 49(17):4775-9. PubMed ID: 2547516
[TBL] [Abstract][Full Text] [Related]
3. The influence of Na+,K(+)-pump blockade on doxorubicin-mediated cytotoxicity and DNA strand breakage in human tumor cells.
Lawrence TS; Davis MA
Cancer Chemother Pharmacol; 1990; 26(3):163-7. PubMed ID: 2162743
[TBL] [Abstract][Full Text] [Related]
4. Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.
De Graff WG; Myers LS; Mitchell JB; Hahn SM
Int J Oncol; 2003 Jul; 23(1):159-63. PubMed ID: 12792789
[TBL] [Abstract][Full Text] [Related]
5. Reduction by caffeine of adriamycin-induced cell killing and DNA damage in Chinese hamster cells: correlation with modulation in intracellular adriamycin content.
Iliakis G; Lazar W
Cancer Res; 1987 May; 47(9):2224-9. PubMed ID: 3552213
[TBL] [Abstract][Full Text] [Related]
6. Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A.
Vichi PJ; Tritton TR
Cancer Res; 1993 Nov; 53(21):5237-43. PubMed ID: 8106144
[TBL] [Abstract][Full Text] [Related]
7. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
[TBL] [Abstract][Full Text] [Related]
8. Comparison of adriamycin- and ouabain-induced cytotoxicity and inhibition of 86rubidium transport in wild-type and ouabain-resistant C3H/10T1/2 mouse fibroblasts.
Landolph JR; Bhatt RS; Telfer N; Heidelberger C
Cancer Res; 1980 Dec; 40(12):4581-8. PubMed ID: 7438092
[TBL] [Abstract][Full Text] [Related]
9. Protection of doxorubicin cytotoxicity by cycloheximide.
Bonner JA; Lawrence TS
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1209-12. PubMed ID: 2541122
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II-independent doxorubicin-induced cytotoxicity in an extremely doxorubicin-resistant cell line.
Bonner JA; Liengswangwong V
Biochem Biophys Res Commun; 1994 Jan; 198(2):582-9. PubMed ID: 8297368
[TBL] [Abstract][Full Text] [Related]
11. Influence of ouabain on cell inactivation by irradiation.
Verheye-Dua FA; Böhm L
Strahlenther Onkol; 1996 Mar; 172(3):156-61. PubMed ID: 8721264
[TBL] [Abstract][Full Text] [Related]
12. Temperature dependence of adriamycin-induced DNA damage in L1210 cells.
Vichi P; Robison S; Tritton TR
Cancer Res; 1989 Oct; 49(20):5575-80. PubMed ID: 2551489
[TBL] [Abstract][Full Text] [Related]
13. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
[TBL] [Abstract][Full Text] [Related]
14. The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity.
Swift LP; Cutts SM; Nudelman A; Levovich I; Rephaeli A; Phillips DR
Cancer Chemother Pharmacol; 2008 Apr; 61(5):739-49. PubMed ID: 17594094
[TBL] [Abstract][Full Text] [Related]
15. DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action.
Sinha BK; Haim N; Dusre L; Kerrigan D; Pommier Y
Cancer Res; 1988 Sep; 48(18):5096-100. PubMed ID: 2842045
[TBL] [Abstract][Full Text] [Related]
16. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.
Fornari FA; Randolph JK; Yalowich JC; Ritke MK; Gewirtz DA
Mol Pharmacol; 1994 Apr; 45(4):649-56. PubMed ID: 8183243
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.
Jensen LH; Dejligbjerg M; Hansen LT; Grauslund M; Jensen PB; Sehested M
BMC Pharmacol; 2004 Dec; 4():31. PubMed ID: 15575955
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.
Swift LP; Rephaeli A; Nudelman A; Phillips DR; Cutts SM
Cancer Res; 2006 May; 66(9):4863-71. PubMed ID: 16651442
[TBL] [Abstract][Full Text] [Related]
19. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.
Pommier Y; Zwelling LA; Kao-Shan CS; Whang-Peng J; Bradley MO
Cancer Res; 1985 Jul; 45(7):3143-9. PubMed ID: 2988762
[TBL] [Abstract][Full Text] [Related]
20. DNA breakage, cytotoxicity, drug accumulation and retention in two human ovarian tumor cell lines AZ224 and AZ364 treated with adriamycin, modulated by verapamil.
Delvaeye M; Verovski V; De Neve W; Storme G
Anticancer Res; 1993; 13(5A):1533-8. PubMed ID: 8239532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
